Nuwellis Announces Peer Reviewed Data Demonstrating 71% Survival with Kidney Replacement Therapy Using a Modified Aquadex in Low-Birth-Weight Preterm Neonates

Stock Information for Nuwellis Inc.

Loading

Please wait while we load your information from QuoteMedia.